Patents by Inventor Ernest W. Yankee

Ernest W. Yankee has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • 8.beta.,12.alpha.,15.beta.-17-Phenyl-18,19,20-trinor-PGE.sub.2 compounds
    Patent number: 3978114
    Abstract: This invention is a group of 8-.beta., 12-.alpha.-PG.sub.2 (prostaglandin-type) analogs having variable chain length, or methyl or phenyl substitution in the hydroxy-substituted side-chain, and processes for making them. These compounds are useful for a variety of pharmacological purposes, including anti-ulcer, inhibition of platelet aggregation, increase of nasal patency, and labor inducement at term.
    Type: Grant
    Filed: October 29, 1974
    Date of Patent: August 31, 1976
    Assignee: The Upjohn Company
    Inventor: Ernest W. Yankee
  • 8.beta.,11.beta.,12.alpha.-17-Phenyl-PGF.sub.2.sub..beta. compounds
    Patent number: 3978112
    Abstract: This invention is a group of 8-.beta., 12-.alpha.-PG.sub.2 (prostaglandin-type) analogs having variable chain length, or methyl or phenyl substitution in the hydroxy-substituted side-chain, and processes for making them. These compounds are useful for a variety of pharmacological purposes, including anti-ulcer, inhibition of platelet aggregation, increase of nasal patency, and labor inducement at term.
    Type: Grant
    Filed: October 29, 1974
    Date of Patent: August 31, 1976
    Assignee: The Upjohn Company
    Inventor: Ernest W. Yankee
  • 8.beta.,11.beta.,12.alpha.-17-Phenyl-18,19,20-trinor-PGF.sub.2.sub..alpha.
    Patent number: 3978113
    Abstract: This invention is a group of 8-.beta., 12-.alpha.-PG.sub.2 (prostaglandin-type) analogs having variable chain length, or methyl or phenyl substitution in the hydroxy-substituted side-chain, and processes for making them. These compounds are useful for a variety of pharmacological purposes, including anti-ulcer, inhibition of platelet aggregation, increase of nasal patency, and labor inducement at term.
    Type: Grant
    Filed: October 29, 1974
    Date of Patent: August 31, 1976
    Assignee: The Upjohn Company
    Inventor: Ernest W. Yankee
  • 8.beta.,11.beta.,12.alpha.-17-Phenyl-18,19,20-trinor-PGE.sub.2 compounds
    Patent number: 3978111
    Abstract: This invention is a group of 8-.beta., 12-.alpha.-PG.sub.2 (prostaglandin-type) analogs having variable chain length, or methyl or phenyl substitution in the hydroxy-substituted side-chain, and processes for making them. These compounds are useful for a variety of pharmacological purposes, including anti-ulcer, inhibition of platelet aggregation, increase of nasal patency, and labor inducement at term.
    Type: Grant
    Filed: October 29, 1974
    Date of Patent: August 31, 1976
    Assignee: The Upjohn Company
    Inventor: Ernest W. Yankee
  • 8.beta.,12.alpha.,15.beta.-17-Phenyl-18,19,20-trinor-PGF.sub.2.sub..beta. c
    Patent number: 3978110
    Abstract: This invention is a group of 8-.beta., 12-.alpha.-PG.sub.2 (prostaglandin-type) analogs having variable chain length, or methyl or phenyl substitution in the hydroxy-substituted side-chain, and processes for making them. These compounds are useful for a variety of pharmacological purposes, including anti-ulcer, inhibition of platelet aggregation, increase of nasal patency, and labor inducement at term.
    Type: Grant
    Filed: October 29, 1974
    Date of Patent: August 31, 1976
    Assignee: The Upjohn Company
    Inventor: Ernest W. Yankee
  • 8.beta., 11.beta., 12.alpha.-PGF.sub.2.sub..beta. -compounds
    Patent number: 3975426
    Abstract: This invention is a group of 8-beta, 12-alpha-PG.sub.2 (prostaglandin-type) analogs having variable chain length, or methyl or phenyl substitution in the hydroxy-substituted side-chain, and processes for making them. These compounds are useful for a variety of pharmacological purposes, including anti-ulcer, inhibition of platelet aggregation, increase of nasal patency, and labor inducement at term.
    Type: Grant
    Filed: October 29, 1974
    Date of Patent: August 17, 1976
    Assignee: The Upjohn Company
    Inventor: Ernest W. Yankee
  • 8.beta., 11.beta., 12.alpha.-PGE.sub.2 compounds
    Patent number: 3969396
    Abstract: This invention is a group of 8-beta, 12-alpha-PG.sub.2 (prostaglandin-type) analogs having variable chain length, or methyl or phenyl substitution in the hydroxy-substituted side-chain, and processes for making them. These compounds are useful for a variety of pharmacological purposes, including anti-ulcer, inhibition of platelet aggregation, increase of nasal patency, and labor inducement at term.
    Type: Grant
    Filed: October 29, 1974
    Date of Patent: July 13, 1976
    Assignee: The Upjohn Company
    Inventor: Ernest W. Yankee